Fasiglifam, TX-875
Product Detail
Khoom cim npe
Pob Loj | Muaj | Nqe (USD) |
Lub npe tshuaj:
(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3 -dihydrobenzofuran-3-yl) acetic acid
SMILES Code:
O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 ) = CC = C12
InChi Code:
InChI = 1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21( 14-22) 17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16, ib. 23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1
InChi Key:
BZCALJIHZVNMGJ-HSZRJFAPSA-N
Lo lus tseem ceeb:
1000413-72-8 ; CAS : 1000413-72-8 ; CAS : 1000413-72-8 ; TAK 875 ; TAK-875 ; TAK 875 ; Fasiglifam
Solubility:Soluble hauv DMSO, tsis nyob hauv dej
Cia:0 - 4 C rau lub sijhawm luv (hnub mus rau lub lis piam), lossis -20 C rau lub sijhawm ntev (hli).
Nqe lus piav qhia:
Fasiglifam (TAK-875) yog ib qho zoo, qhov ncauj, thiab xaiv GPR40 agonist.
Hom phiaj: GPR40 agonist